Thesis icon

Thesis

Type 1 insulin-like growth factor receptor inhibition as treatment for urological cancer

Abstract:

The type 1 insulin-like growth factor receptor (IGF-1R) is a receptor tyrosine kinase that mediates diverse cellular functions including growth, differentiation, migration and apoptosis protection. IGF-1R signalling has been implicated in tumorigenesis in a variety of cancers, and IGF-1R inhibitory drugs are currently undergoing clinical evaluation. Previous work in our laboratory has shown IGF-1R over-expression in urological cancers at both the mRNA and protein level, thus making it a po...

Expand abstract

Actions

  • Cite

  • Print

Access Document

Files:

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Oxford college:
Christ Church
Role:
Author

Contributors

Role:
Supervisor

More from this funder
Funding agency for:
Chitnis, M

Publication date:
2013
DOI:
Type of award:
DPhil
Level of award:
Doctoral
Awarding institution:
Oxford University, UK

Language:
English
Keywords:
Subjects:
UUID:
uuid:21282ce9-ce6b-4d26-b262-a3fca6d9c9fc
Local pid:
ora:7255
Deposit date:
2013-09-04

Terms of use

Views and Downloads





If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP